Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pembrolizumab monotherapy trial (Japan, jRCT2080222403)
jRCT2080222403Phase 1Completed
- Start
- Feb 2014
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 1, single-arm trial of pembrolizumab. Started Feb 2014; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080222403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222403.